# OnCo record lipegfilgrastim (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/lipegfilgrastim/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "lipegfilgrastim" ;
  schema:name "Lipegfilgrastim"@en ;
  schema:description "Lipegfilgrastim (Lonquex) is a once-per-chemotherapy-cycle white cell booster used in Europe, similar to pegfilgrastim, for adults and children from two years old."@en ;
  schema:url <https://onco.cc/drugs/lipegfilgrastim/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Lipegfilgrastim> ;
  schema:citation <https://doi.org/10.1186/1471-2407-13-386>, <https://www.ema.europa.eu/en/medicines/human/EPAR/lonquex> ;
  onco:status "approved" ;
  onco:tag "ema-list", "supportive" ;
  onco:modality "Glycopegylated recombinant G-CSF" ;
  schema:alternateName "Lonquex" ;
  onco:approval "EU 2013: Reduction in duration of neutropenia and febrile neutropenia after cytotoxic chemotherapy in adults (children from 2 years added 2021)" ;
  onco:related <https://onco.cc/drugs/pegfilgrastim/> ;
  onco:technologies <https://onco.cc/technologies/g-csf-growth-factors/> ;
  onco:companies <https://onco.cc/companies/teva/> ;
  onco:trials <https://onco.cc/trials/xm22-03/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-xm22-03-bondarenko-bmc-cancer-2013/> .